Trial · NCT03738618
Results by group393
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 393
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cumulative Ongoing Pregnancy Rate After the Fresh Cycle and Cryopreserved Cycles Initiated Within 12 Months From the Start of Controlled Ovarian Stimulation (COS) | FE 999049 (Follitropin Delta) | 43.3 | percentage of participants | ||
| Cumulative Ongoing Pregnancy Rate After the Fresh Cycle and Cryopreserved Cycles Initiated Within 12 Months From the Start of Controlled Ovarian Stimulation (COS) | Placebo | 0.0 | percentage of participants | ||
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Fresh cycle | 22.0 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | Placebo | Fresh cycle | 0.0 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 47.8 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | Placebo | Cryopreserved cycles | 0 | percentage of participants | |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Including Duration | FE 999049 (Follitropin Delta) | Total number of days until ongoing pregnancy 12 study months | 134.7 | Standard Deviation 87.2 | days |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Including Duration | FE 999049 (Follitropin Delta) | Total number of days until ongoing pregnancy 12 calendar months | 130.1 | Standard Deviation 77.8 | days |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Measured in Number of Cycles Before Achieving Ongoing Pregnancy | FE 999049 (Follitropin Delta) | Number of cycles until ongoing pregnancy 12 study months | 1.8 | Standard Deviation 1.0 | Cycles |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Measured in Number of Cycles Before Achieving Ongoing Pregnancy | FE 999049 (Follitropin Delta) | Number of cycles until ongoing pregnancy 12 calendar months | 1.7 | Standard Deviation 1.0 | Cycles |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 32.7 | % of viable fetus/blastocyst transfer | |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 30.6 | % of viable fetus/blastocyst transfer | |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | All cycles | 31.6 | % of viable fetus/blastocyst transfer | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 26.8 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | Fresh cycle | 0.0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 58.0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | Cryopreserved cycles | 0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | All cycles | 52.0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | All cycles | 0.0 | percentage of participants | |
| Vital Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 23.5 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03738618/results